We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$153M
2
RUN icon
Sunrun
RUN
+$94.3M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$83.8M
4
DT icon
Dynatrace
DT
+$67.2M
5
ED icon
Consolidated Edison
ED
+$56.8M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$71.8M
2
TXG icon
10x Genomics
TXG
+$62.3M
3
CZR icon
Caesars Entertainment
CZR
+$60.8M
4
DNLI icon
Denali Therapeutics
DNLI
+$53.1M
5
PENN icon
PENN Entertainment
PENN
+$42M

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVLA
926
Palvella Therapeutics
PVLA
$2.02B
– –
-754
Closed -$125K
KLRS
927
Kalaris Therapeutics
KLRS
$96.4M
– –
-1,087
Closed -$688K
ACCD
928
DELISTED
Accolade Inc
ACCD
– –
-50,000
Closed -$1.94M
ITCI
929
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-198,494
Closed -$5.09M
NARI
930
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-30,000
Closed -$2.07M
PSTX
931
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-25,000
Closed -$222K
CNTG
932
DELISTED
Centogene N.V. Common Shares
CNTG
– –
-87,465
Closed -$827K
TWOU
933
DELISTED
2U Inc
TWOU
– –
-41,015
Closed -$41.7M
ETRN
934
CALL
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-2,150,000
Closed -$18.2M
AFIB
935
DELISTED
Acutus Medical Inc
AFIB
– –
-50,000
Closed -$1.49M
PXD
936
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-1,200
Closed -$103K
FRLN
937
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-1,211
Closed -$284K
AMTI
938
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-40,000
Closed -$1.27M
ARCE
939
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
– –
-27,020
Closed -$1.1M
GTH
940
DELISTED
Genetron Holdings Limited ADS
GTH
– –
-45,390
Closed -$1.63M
FOCS
941
DELISTED
Focus Financial Partners Inc. Class A
FOCS
– –
-179,979
Closed -$5.9M
ARNC
942
DELISTED
Arconic Corporation
ARNC
– –
-216,819
Closed -$4.13M
AEPPZ
943
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
– –
-50,000
Closed -$2.45M
HGEN
944
DELISTED
HUMANIGEN, INC.
HGEN
– –
-31,052
Closed -$330K
EVLO
945
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
– –
-1,637
Closed -$173K
AQUA
946
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
– –
-325,997
Closed -$6.92M
OSH
947
DELISTED
Oak Street Health, Inc.
OSH
– –
-65,000
Closed -$3.47M
TIG
948
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
– –
-15,000
Closed -$229K
AUY
949
CALL
DELISTED
Yamana Gold, Inc.
AUY
– –
-40,700
Closed -$231K
DCT
950
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
– –
-132,823
Closed -$6.03M
36 37
38
39 40

Similar funds

CIG
CCM Investment Group Northfield, Minnesota $946M AUM
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
SWC
Spectrum Wealth Counsel Indianapolis, Indiana $833M AUM 10.83% 1-Year Est. Return
KTA
Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.